MacroGenics, Inc.
MGNX
$3.08
-$0.02-0.65%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 41.23M | 72.84M | 22.24M | 13.19M | 19.35M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 41.23M | 72.84M | 22.24M | 13.19M | 19.35M |
| Cost of Revenue | 44.09M | 44.30M | 49.70M | 45.10M | 44.38M |
| Gross Profit | -2.86M | 28.54M | -27.46M | -31.91M | -25.03M |
| SG&A Expenses | 9.24M | 9.91M | 9.30M | 10.72M | 27.81M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 53.32M | 54.20M | 59.00M | 55.82M | 72.19M |
| Operating Income | -12.10M | 18.64M | -36.76M | -42.62M | -52.84M |
| Income Before Tax | -14.93M | 16.82M | -36.15M | -41.04M | -14.48M |
| Income Tax Expenses | -777.00K | -- | 105.00K | -- | 944.00K |
| Earnings from Continuing Operations | -14.16M | 16.82M | -36.25M | -41.04M | -15.42M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -14.16M | 16.82M | -36.25M | -41.04M | -15.42M |
| EBIT | -12.10M | 18.64M | -36.76M | -42.62M | -52.84M |
| EBITDA | -10.39M | 20.43M | -34.85M | -40.85M | -50.78M |
| EPS Basic | -0.22 | 0.27 | -0.57 | -0.65 | -0.25 |
| Normalized Basic EPS | -0.15 | 0.17 | -0.36 | -0.41 | -0.51 |
| EPS Diluted | -0.22 | 0.27 | -0.57 | -0.65 | -0.25 |
| Normalized Diluted EPS | -0.15 | 0.17 | -0.36 | -0.41 | -0.51 |
| Average Basic Shares Outstanding | 63.28M | 63.23M | 63.14M | 62.97M | 62.78M |
| Average Diluted Shares Outstanding | 63.28M | 63.28M | 63.14M | 62.97M | 62.78M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |